Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes

This publication has 15 references indexed in Scilit:

• VIP_1–12 Is a Ligand for the CD₄/Human Immunodeficiency Virus Receptor
  Annals of the New York Academy of Sciences, 1988
• Peptide T from human immunodeficiency virus envelope does not interact with hepatic, intestinal and colonic vasoactive intestinal peptide (VIP) receptors
  Peptides, 1988
• A new type of functional VIP receptor has an affinity for helodermin in human SUP‐T1 lymphoblasts
  FEBS Letters, 1988
• [d‐Phe⁴]Peptide histidine‐isoleucinamide ([d‐Phe⁴]PHI), a highly selective vasoactive‐intestinal‐peptide (VIP) agonist, discriminates VIP‐preferring from secretin‐preferring receptors in rat pancreatic membranes
  European Journal of Biochemistry, 1987
• CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxis
  FEBS Letters, 1987
• A fragment of vasoactive intestinal peptide, VIP(10–28), is an antagonist of VIP in the colon carcinoma cell line, HT29
  Peptides, 1986
• Interaction of vasoactive intestinal peptide (VIP) and N‐terminally modified VIP analogs with rat pancreatic, hepatic and pituitary membranes
  European Journal of Biochemistry, 1986
• Effects of HIS1 modifications on the ability of vasoactive intestinal peptide to stimulate adenylate cyclase from rat and human tissues
  Peptides, 1984
• SOLID‐PHASE SYNTHESIS OF PORCINE VASOACTIVE INTESTINAL PEPTIDE
  International Journal of Peptide and Protein Research, 1980
• A highly sensitive adenylate cyclase assay
  Analytical Biochemistry, 1974